Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-07 @ 1:51 PM
Study NCT ID:
NCT01751451
Status:
COMPLETED
Last Update Posted:
2021-11-19
First Post:
2012-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-28
Completion Date Type:
ACTUAL
First Submit Date:
2012-12-14
First Submit QC Date:
None
Study First Post Date:
2012-12-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-31
Results First Submit QC Date:
None
Results First Post Date:
2021-11-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-25
Last Update Post Date:
2021-11-19
Last Update Post Date Type:
ACTUAL